A phase I trial of erlotinib in patients with nonprogressive glioblastoma multiforme postradiation therapy, and recurrent malignant gliomas and meningiomas

Jeffrey J. Raizer, Lauren E. Abrey, Andrew B. Lassman, Susan M. Chang, Kathleen R. Lamborn, John G. Kuhn, W. K.Alfred Yung, Mark R. Gilbert, Kenneth D. Aldape, Patrick Y. Wen, Howard A. Fine, Minesh Mehta, Lisa M. DeAngelis, Frank Lieberman, Timothy F. Cloughesy, H. Ian Robins, Janet Dancey, Michael D. Prados

Research output: Contribution to journalArticlepeer-review

36 Scopus citations

Fingerprint

Dive into the research topics of 'A phase I trial of erlotinib in patients with nonprogressive glioblastoma multiforme postradiation therapy, and recurrent malignant gliomas and meningiomas'. Together they form a unique fingerprint.

INIS

Pharmacology, Toxicology and Pharmaceutical Science